Bausch Health Companies Inc (NYSE:BHC) price on current trading day, rose 0.37% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $8.15.
A look at the stock’s price movement, the close in the last trading session was $8.12, moving within a range at $8.04 and $8.17. The beta value (5-Year monthly) was 0.745. Turning to its 52-week performance, $11.46 and $3.96 were the 52-week high and 52-week low respectively. Overall, BHC moved -14.21% over the past month.
Bausch Health Companies Inc’s market cap currently stands at around $3.00 billion, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 2.52B for the company’s revenue for the quarter, with a low and high estimate of 2.47B and 2.58B respectively. The average forecast suggests up to a 4.59% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 9.57B, representing a 9.32% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BHC is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 1 recommend BHC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BHC’s current price about -2.62% and -3.10% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 46.46, while 7-day volatility ratio is 3.70% and 3.00% in the 30-day chart. Further, Bausch Health Companies Inc (BHC) has a beta value of 0.69, and an average true range (ATR) of 0.28. Analysts have given the company’s stock an average 52-week price target of $8, forecast between a low of $7 and high of $10. Looking at the price targets, the low is 14.11% off current price level while to achieve the yearly target high, price needs to move -22.7%. Nonetheless, investors will most likely welcome a 1.84% jump to $8 which is the analysts’ median price.
If we refocus on Bausch Health Companies Inc (NYSE:BHC), historical trading data shows that trading volumes averaged 1.35 over the past 10 days and 2.09 million over the past 3 months. The company’s latest data on shares outstanding shows there are 365.24 million shares.
The 21.08% of Bausch Health Companies Inc’s shares are in the hands of company insiders while institutional holders own 61.07% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 9.34 million on 2024-11-15, giving us a short ratio of 4.7. The data shows that as of 2024-11-15 short interest in Bausch Health Companies Inc (BHC) stood at 275.0 of shares outstanding, with shares short falling to 12.03 million registered in 2024-10-15. Current price change has pushed the stock 1.62% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BHC stock continues to rise going into the next quarter.